1-(4-(4-Amino-7-ethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea

ID: ALA4572972

PubChem CID: 155563104

Max Phase: Preclinical

Molecular Formula: C22H25N7O2

Molecular Weight: 419.49

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCn1cc(-c2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)cc2)c2c(N)ncnc21

Standard InChI:  InChI=1S/C22H25N7O2/c1-5-29-11-15(18-19(23)24-12-25-20(18)29)13-6-8-14(9-7-13)26-21(30)27-17-10-16(31-28-17)22(2,3)4/h6-12H,5H2,1-4H3,(H2,23,24,25)(H2,26,27,28,30)

Standard InChI Key:  SAGFFDKEESOZKZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    8.7724  -23.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4780  -24.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4739  -24.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1878  -23.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1798  -24.5311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6371  -25.6507    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6359  -26.4702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3440  -26.8792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3422  -25.2418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0508  -25.6471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0556  -26.4657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8357  -26.7142    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3130  -26.0490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8279  -25.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3398  -24.4246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2484  -27.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2411  -24.6854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0590  -24.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4728  -23.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0695  -23.2810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2481  -23.2775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8379  -23.9819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4825  -22.5759    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2996  -22.5809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7126  -21.8758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7038  -23.2912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5210  -23.2962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9936  -23.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7774  -22.8966    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0018  -22.6394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0656  -27.4145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  6  7  2  0
  7  8  1  0
  8 11  2  0
 10  9  2  0
  9  6  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  9 15  1  0
 12 16  1  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28  1  2  0
  1 29  1  0
 29 30  1  0
 30 27  2  0
 16 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4572972

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 419.49

Molecular Weight (Monoisotopic): 419.2070

AlogP: 4.63

#Rotatable Bonds: 4

Polar Surface Area: 123.89

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.28

CX Basic pKa: 6.22

CX LogP: 4.08

CX LogD: 4.00

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.44

Np Likeness Score: -1.44

References

1. Yuan X, Chen Y, Zhang W, He J, Lei L, Tang M, Liu J, Li M, Dou C, Yang T, Yang L, Yang S, Wei Y, Peng A, Niu T, Xiang M, Ye H, Chen L..  (2019)  Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.,  62  (8): [PMID:30939008] [10.1021/acs.jmedchem.9b00223]

Source

Source(1):

• Scientific Literature